Meridian Financial »

Alnylam Pharmaceuticals shares owned by Meridian Financial

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Meridian Financial from 13F filings

Historical chart of Meridian Financial investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Meridian Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Meridian Financial

Quarter filed Position value Share count Share price at filing
2024-06-30 $219k 900 243.00
2023-06-30 $234k 1.2k 189.94
2023-03-31 $247k 1.2k 200.32

More positions owned by Meridian Financial

J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds Small Cp Etf (VB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Ser Tr S&p Divid Etf (SDY)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Spdr Ser Tr Portfolio S&p600 (SPSM)

View all positions for Meridian Financial

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
FMR
BlackRock
Wellington Management Company
Baillie Gifford & Co
Dodge & Cox
Capital Research and Management Company - Division 3
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Capital Research Global Investors
Geode Capital Management
Jpmorgan Chase & Co
Susquehanna International

View all funds holding Alnylam Pharmaceuticals